NYSE:DAR • US2372661015
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DARLING INGREDIENTS INC (DAR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-13 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-13 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-12 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-02 | TD Cowen | Upgrade | Hold -> Buy |
| 2025-10-24 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-24 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-08 | B of A Securities | Initiate | Buy |
| 2025-10-08 | Jefferies | Maintains | Buy -> Buy |
| 2025-07-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-25 | Baird | Downgrade | Outperform -> Neutral |
| 2025-07-07 | Jefferies | Maintains | Buy -> Buy |
| 2025-04-25 | Baird | Maintains | Outperform -> Outperform |
| 2025-04-15 | Baird | Maintains | Outperform -> Outperform |
| 2025-04-15 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-29 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-23 | Stephens & Co. | Reiterate | Overweight |
| 2024-10-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-25 | Jefferies | Maintains | Buy -> Buy |
| 2024-10-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-07 | Jefferies | Maintains | Buy -> Buy |
| 2024-09-13 | TD Cowen | Maintains | Hold -> Hold |
| 2024-07-26 | Jefferies | Maintains | Buy -> Buy |
| 2024-07-12 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.788B 3.92% | 5.715B -15.81% | 6.136B 7.36% | 6.441B 4.97% | 6.614B 2.69% | 7.014B 6.05% | N/A | N/A | |
| EBITDA YoY % growth | 1.102B 0.87% | 785.733M -28.73% | N/A 21.55% | 1.426B 49.31% | 1.541B 8.06% | 1.793B 16.35% | 1.963B 9.48% | N/A | |
| EBIT YoY % growth | 600.471M -14.01% | 281.908M -53.05% | 413.796M 46.78% | 695.9M 68.17% | 848.49M 21.93% | 954.87M 12.54% | N/A | N/A | |
| Operating Margin | 8.85% | 4.93% | 6.74% | 10.80% | 12.83% | 13.61% | N/A | N/A | |
| EPS YoY % growth | 3.94 -12.44% | 1.73 -56.09% | 0.41 -76.30% | 2.52 513.98% | 3.31 31.30% | 3.87 17.04% | 5.71 47.52% | 6.67 16.81% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.53 433.99% | 0.70 596.16% | 0.70 479.28% | 0.83 137.46% | 0.74 38.16% | 0.82 17.61% | 0.92 32.99% | 0.93 12.41% | 0.97 31.74% | 1.06 29.15% | 1.25 35.47% |
| Revenue Q2Q % growth | 1.565B 13.36% | 1.623B 9.55% | 1.583B 1.22% | 1.58B -7.59% | 1.581B 1.02% | 1.62B -0.18% | 1.627B 2.78% | 1.621B 2.59% | 1.637B 3.54% | 1.644B 1.48% | 1.648B 1.29% |
| EBITDA Q2Q % growth | 324.95M 71.21% | 345.72M 4.23% | 324.85M -34.02% | 344.69M 23.01% | 323.41M -0.47% | 330.58M -4.38% | 339.97M 4.65% | 351.27M 1.91% | 355.22M 9.84% | 370.37M 12.04% | 401.07M 17.97% |
| EBIT Q2Q % growth | 146.16M 121.59% | 180.41M 107.88% | 175.98M 42.67% | 188.66M 37.01% | 185.64M 27.01% | 196.77M 9.07% | 193.26M 9.82% | 206.85M 9.64% | N/A | N/A | N/A |
All data in USD
19 analysts have analysed DAR and the average price target is 62.7 USD. This implies a price increase of 18.51% is expected in the next year compared to the current price of 52.91.
DARLING INGREDIENTS INC (DAR) will report earnings on 2026-04-22, after the market close.
The consensus EPS estimate for the next earnings of DARLING INGREDIENTS INC (DAR) is 0.53 USD and the consensus revenue estimate is 1.56B USD.
The number of analysts covering DARLING INGREDIENTS INC (DAR) is 19.